The binding of human fibrinogen to germ-tubes and mycelium of Candida albicans, forms usually found in infected tissues, was studied in vitro by an immunofluorescence assay. Binding was quantified by using 251-labelled fibrinogen. The degree of binding differed according to the morphological form of the fungus. Binding relative to that of the yeast form was greater for mycelium (12-fold) than for germ-tube (7.7-fold). Pretreatment of yeasts with fragments D and E (terminal degradation products of fibrinogen) before fibrinogen binding showed that fragment D possessed a higher affinity for C. albicans than fragment E. Binding of fibrinogen was diminished when C. albicans was pretreated with 2-mercaptoethanol alone or in combination with pronase, or pretreated with a-mannosidase or trypsin. Binding was not decreased by pretreatment with pronase alone or chitinase. Inhibition experiments using C. albicans dialysed culture filtrate, C. albicans mannan, chitin, sugars or amino sugars were done by preabsorbing the fibrinogen with each of the above mentioned compounds. C. albicans dialysed culture filtrate inhibited the binding more strongly than C. albicans mannan. However, fibrinogen binding to C. albicans was not significantly reduced by mannose, several other sugars or chitin. These studies demonstrate the existence of a fibrinogen-binding factor (FBF) strongly associated with the surface of germ-tube and filamentous forms of C. albicans, and indicate a possible role for FBF in the pathogenicity of C. albicans.
INTRODUCTION
Candida albicans is a dimorphic pathogen. As a commensal, it grows primarily as a yeast (blastospores), but in infected tissues, blastospores and filamentous forms are simultaneously found (Odds, 1979) . The mycelium, initiated by germ-tubes, plays a role in the pathogenicity of C. albicans, particularly in colonization of the host. Kimura & Pearsall(l980) have shown that the degree of fungal adherence to host epithelial cells is correlated with the formation of germtubes.
The interactions of C. albicans with serum proteins are of considerable interest, since exposure of C. albicans to mammalian serum results in a variety of morphological effects, such as germtube induction (Taschdjian et al., 1960; Hasenclever, 1978) . Ray & Wuepper (1976) have demonstrated that C. albicans activates the alternative complement pathway, resulting in the formation of chemotactic factors, and Kozutsumi et al. (1980) isolated a protein from rabbit serum which binds to yeast mannan (MBP) . MBP has the properties of a lectin and may have a role in defence against pathogenic yeasts (Bull & Turner, 1984 ). An analogous binding protein was isolated from human and bovine sera (Kawasaki et al., 1985) . A role for coagulation proteins in the pathogenicity of C. albicans has been little documented, although envisaged by Maisch & Calderone (1 98 l), who examined adherence of C . albicans to a fibrin-platelet matrix formed in In the present study, binding of human fibrinogen to the surface of germ-tubes and mycelium of C . albicans was investigated by immunofluorescence and quantified by using 251-labelled fibrinogen. The effect of various inhibitors and enzymes pretreatment on binding was also studied.
METHODS
Organisms and culture conditions. Candida albicans 1066 (serotype A) originally isolated from a case of candida septicaemia was used throughout. Blastospores were grown at 37 "C on Sabouraud glucose agar (Merck) for 24 h.
Germ-tubes amd mycelium were obtained by incubation of 24-h-old blastospores for various times (1,2,4, 8 and 24 h) at 37 "C in Medium 199 (Flow Laboratories).
Zmmuno$uorescence assay. Two sources of fibrinogen were used : (i) purified human fibrinogen, free of factor XI11 (Diagnostica stago) and (ii) whole fresh human plasma.
Fungal elements were washed twice in 0.15 M-phosphate-buffered saline (PBS), pH 7.2, containing 5% (w/v) sodium citrate (PBSC) and adjusted to 5 x lo6 cells ml-l . Portions (0.1 ml) of suspension were" centrifuged at 500 g for 15 rnin and the pellets were resuspended in 0.2 ml purified fibrinogen solution (0.25 mg ml-I in PBSC) or in 0.2 ml whole fresh plasma. After 30 rnin incubation at 37 "C, the fungi were washed twice in PBS and resuspended in 50 pl PBSC. One drop (20 pl) was placed on a microscope slide and allowed to dry. Then 20 p1 rabbit anti-human fibrinogen serum (Diagnostica stago) at 1/100 dilution in PBSC was added. Slides were placed in a moist chamber, incubated for 30 rnin at 37 "C and washed three times in PBSC. Fluorescein-isothiocyanate-conjugated goat antirabbit IgG (20 p11/100 dilution; Biosis) was added. Slides were incubated for 30 rnin at 37 "C, washed three times in PBSC and mounted in PBS containing 90% (v/v) glycerol. They were observed under a Nikon microscope equipped for epifluorescence.
2SZ-Labelled jbrinogen binding assay. Human fibrinogen radiolabelled with 251 (specific activity, 137.5 pCi mg-l, 5.09 MBq mg-l) was from Amersham. Fungal cells (24 h blastospores, 2 h germ-tubes and 24 h mycelium were washed twice in PBSC. The reaction mixture consisted of 0.1 ml8% (v/v) fungal suspension and 0.1 ml 1251-labelled fibrinogen (500 pg ml-l). After incubation for 30 rnin at room temperature the fungi were sedimented by centrifugation (15min at 2000g) and were washed six times in PBSC. Radioactivity in the sediment was measured in a y-spectrometer (Kontron MDA 312). For determination of surface areas, a blastospore was considered as a microsphere (5 pm diameter), while a germ-tube was considered as a cylinder (3 pm diameter and 15 pm length) plus a microsphere of 5 pm diameter. Mycelium was considered as a cylinder of 5 pm diameter and 250 pm length. For germ-tubes, the surface area used for determinations was the tube surface only. Data presented are mean values from triplicate experiments.
Competitive binding by jbrinogen fragments D and E. Competitive binding to the surface of 24-h-old mycelium was investigated between non-radiolabelled fibrinogen fragments D or E (Diagnostica stago) and 251-labelled fibrinogen. In the first phase of the assay, mycelial cells (0.1 ml) were incubated with 50 pl fragment D or fragment E (3-50 pg ml-l) for 30 rnin at room temperature. In the second stage, 50 pl 251-labelled fibrinogen (100 pg ml-l) was added. After incubation for 30 rnin at room temperature, the mycelium was washed six times in PBSC by centrifugation (1 5 min at 2000 g),and the radioactivity in the sediment was measured.
Binding inhibition assays. Reaction mixtures consisted of 50 pl iodinated ( I 251) fibrinogen (100 pg ml-I) and 50 pl inhibitor at different concentrations. After 30 rnin at room temperature, 0.1 ml24-h-old mycelial suspension (8%, v/v) was added and the radioactivity in the sediment was measured after 30 rnin of contact at room temperature and several washings. The following substances were tested for their possible inhibitory effect. Exposure of mycelial surface to 2-mercaptoethanol and enzymes. SH-Reducing treatment. Washed mycelium (1 mg) was suspended in 2 mlO.15 M-PBS, pH 7.2, containing 0.2 M-Zmercaptoethanol and incubated for 1 h at 37 "C. Pronase E treatment. The mycelium (1 mg) was treated for 1 h at 37 "C with 250 pg pronase E (Merck) and 0.2 M-2-mercaptoethanol in 0.15 M-PBS, pH 7.6, (2 ml). Some mycelium was treated with pronase E without the reducing 
RESULTS
Binding offibrinogen to C. albicans A study of the binding of fibrinogen to C. albicans by immunofluorescence indicated that no non-budding blastospores showed binding. Of the budding blastospores, produced under budding conditions or under hyphae-inducing conditions, only a few exhibited a strong fluorescence of their emerging bud. Fig. 1 (e) shows a fluorescent bud and a fluorescent hypha emerging from a parent yeast under hyphae-inducing conditions. After 1 h (Fig. 1 a) or 2 h (Fig.  l b ) germ-tubes showed very strong binding on all the surface of the emerging element. The fluorescence exhibited was mostly homogeneous (Fig. 1 d ) and 8-h-old mycelium (Figs 1 e and f) was also very strongly fluorescent. In 3-d-old mycelium (Fig. l c ) cell-wall fluorescence was heterogeneous and diminished compared with newly-formed germ-tubes (Figs 1 a and b) . A study by immunofluorescence assay of fibrinogen binding with whole fresh plasma gave binding patterns identical to those obtained with pure fibrinogen.
Binding of * 251-labelled fibrinogen confirmed the observations from immunofluorescence microscopy. When the surface area of fungus exposed to fibrinogen was used as the denominator for measurement of binding, the mean value for the number of bound fibrinogen molecules per mm2 was 34 x lo7 & 2 x lo7 (SD) for blastospores, 265 x lo7 & 6 x lo7 (SD) for germ-tubes and 408 x lo7 & 9 x lo7 (SD) for mycelium. Thus, fibrinogen binding relative to that of blastospores was 12 times greater for mycelium and 7.7 times greater for germ-tubes.
A study of the capacity of mycelium to bind fibrinogen (Fig. 2) showed that, for 8 p1 fungal material, 100% binding was obtained from 250 pg radiolabelled fibrinogen ml-l (final concentration):ln the following inhibition experiments, the [ 251]fibrinogen concentration used was 25 pg ml-l, corresponding to 33% binding.
Fibrinogen binding after binding offibrinogen fragments D and E
The binding of fibrinogen fragments on the mycelial surface of C. albicans depended on the concentrations used (Fig. 3) . The binding of fragments D or E is expressed as the percentage inhibition of radiolabelled fibrinogen binding. For 50 pg ml-l of these fragments, inhibition of binding was easily obtained with fragment D (52% inhibition), but only moderately with fragment E ( 1 1 % inhibition).
Inhibition of fibrinogen binding by yeast extracts and other substances
Only dialysed culture filtrate strongly inhibited the fibrinogen binding. Thus 75 % inhibition was observed with 250 pg filtrate (Fig. 4) . At the same concentration, the observed inhibition with mannan extracted from C. albicans (Fig. 4) was less strong (38%). Slight inhibition was observed with chitin (< 7% inhibition with 250 pg) (Fig. 4) . The specificity of the inhibition was tested by examining the effect of other constituents on binding. 
Ejects of 2-mercaptoethanol and pretreatment with enzymes
The binding of fibrinogen to C. albicans was quantified after treatment of 24-h-old mycelium with pronase E alone, pronase E and 0.2 M-2-mercaptoethano1, 0.2 M-2-mercaptoethanol alone, trypsin, a-mannosidase or chitinase (Table 1) . Pronase E enhanced fibrinogen binding, and chitinase did not reduce binding significantly, but a-mannosidase, trypsin, 2-mercaptoethanol and 2-mercaptoethanol + pronase resulted in a significant loss of fibrinogen-binding activity.
DISCUSSION
The binding of host proteins, particularly of human fibronectin (Skerl et al., 1984) , to blastospores of C. albicans is considered to play a role in adherence of C. albicans to mammalian cells. With human fibrinogen, the present study demonstrated that binding can be obtained with filamentous forms (germ-tubes and mycelium). However, we could observe with only a few budding cells the binding of fibrinogen at their buds; no binding was observed with mother cells. The fibrinogen-binding factor (FBF) appeared early during germ-tube formation ; it was detected within 30 min and disappeared as the mycelium aged. These observations were probably associated with the ultrastructural changes in the cell wall during germ-tube formation from blastospores of C. albicans (Cassone et al., 1973) . The binding of fibrinogen to the filamentous forms, usually found in infected tissues (Odds, 1979) and implicated in adherence processes (Kimura & Pearsall, 1980) , may suggest a role for FBF in the pathogenicity of C. albicans. The FBF could account for adherence of C. albicans to the fibrin-platelet matrix formed in uitro, as demonstrated by Maisch & Calderone (1980 , 1981 . In addition, this binding was not inhibited by plasma components. The binding site of fibrinogen is probably located on fragment D because this has a higher affinity for C . albicans than fragment E. Pretreatment of germ-tubes with 2-mercaptoethanol alone or in combination with pronase decreased fibrinogen bindihg, but the difference between the two pretreatments was not significant (Table 1 ). It seems possible that 2-mercaptoethanol releases the FBF. These results are comparable with the observations of Davies & Wayman (1975) and Chattaway et al. (1976) in which 2-mercaptoethanol was found to release a large amount of cell wall material from C. albicans blastospores. These released components may be implicated in concanavalin A agglutination (Cassone et al., 1978; Trorichin et al., 1981) . Pretreatment with trypsin also decreased fibrinogen binding. The role of other cell wall components was studied. Preatreatment with chitinase gave no significant decrease in fibrinogen binding, but a-mannosidase released mannose from the cell wall of C. albicans and deireased the binding.
Mannan and proteins may be components of FBF. However, purified mannan did not significantly inhibit the binding at low concentration and inhibition was obtained only at high concentration. With dialysed culture filtrate of C. albicans, on the other hand, a strong binding inhibition was obtained even at low concentration (Fig. 4) . These results confirm that proteins and glycosidic components present on the mycelial surface are involved in fibrinogen binding.
